Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Nanoemulsions with minoxidil and clove oil effectively target hair follicles for better alopecia treatment.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CD2 might be a new treatment target for patchy alopecia areata.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Chemokine signaling is important for hair development.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

ECM1-modified stem cells can effectively treat liver cirrhosis.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Blocking interferon-gamma might help treat various autoimmune diseases.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Effective PCOS treatments require targeting specific signaling pathways.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.